Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Joyn Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Joyn Bio

Joyn Bio

Series A

Joyn Bio, a Bayer-Ginkgo venture, develops plant probiotics to reduce reliance on nitrogen fertilizer.

HQ
Boston, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Joyn Bio, a joint venture founded by Bayer and Ginkgo Bioworks, focuses on developing probiotics for plants to address significant agricultural challenges. The company's core mission is to engineer microbes that can provide cereal crops with their nitrogen needs, thereby reducing the reliance on nitrogen fertilizers and mitigating their environmental impact. Joyn Bio integrates expertise from microbiologists, synthetic biologists, plant scientists, and ecologists to create innovative agricultural solutions.

Notable affiliations include Bayer and Ginkgo Bioworks, two giants in the fields of pharmaceuticals and synthetic biology, respectively. Key achievements include advancements in microbial engineering that promise to revolutionize nitrogen fixation in crops. The overall impact of Joyn Bio's work is significant, aiming to enhance sustainable agriculture practices and reduce the environmental footprint of farming.

Joyn Bio - Similar Companies

Pivot Bio logo

Pivot Bio

pivotbio.com

Switch Bioworks logo

Switch Bioworks

switchbioworks.com

Growcentia logo

Growcentia

growcentia.com

BioConsortia logo

BioConsortia

bioconsortia.com

Intrinsyx Bio logo

Intrinsyx Bio

intrinsyxbio.com

Kula Bio logo

Kula Bio

kulabio.com

Nitrogenics logo

Nitrogenics

Biowish Technologies logo

Biowish Technologies

Robigo logo

Robigo

robigo.bio

BiomEdit logo

BiomEdit

biomedit.com

ZBiotics logo

ZBiotics

zbiotics.com

Omnicrobe logo

Omnicrobe

Alga Biosciences logo

Alga Biosciences

alga.bio

Microbial Machines logo

Microbial Machines

AgBiome logo

AgBiome

agbiome.com

Joyn Bio - Quick Facts

Who are Joyn Bio's competitors?

Companies similar to Joyn Bio include Pivot Bio, Switch Bioworks, Growcentia and BioConsortia.

When was Joyn Bio founded?

Joyn Bio was founded in 2017.

Where is Joyn Bio's headquarters located?

Joyn Bio's headquarters is located in Boston, MA, US.

When was Joyn Bio's last funding round?

Joyn Bio's most recent funding round was for $100M (USD) in March 2018.

How much has Joyn Bio raised to-date?

As of Mar 20, 2018, Joyn Bio has raised a total of $200M (USD).

How many employees does Joyn Bio have?

Joyn Bio has 125 employees as of Feb 4, 2024.

Joyn Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Probiotics
Tags
  • AgTech
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified